BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10623697)

  • 1. Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival.
    Mackay HJ; Cameron D; Rahilly M; Mackean MJ; Paul J; Kaye SB; Brown R
    J Clin Oncol; 2000 Jan; 18(1):87-93. PubMed ID: 10623697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLH1 expression predicts the response to preoperative therapy and is associated with PD-L1 expression in esophageal cancer.
    Momose K; Yamasaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Oncol Lett; 2017 Jul; 14(1):958-964. PubMed ID: 28693258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
    Sparano JA; Gray RJ; Makower DF; Pritchard KI; Albain KS; Hayes DF; Geyer CE; Dees EC; Perez EA; Olson JA; Zujewski J; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Paik S; Wood WC; Ravdin P; Keane MM; Gomez Moreno HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Atkins JN; Berenberg JL; Sledge GW
    N Engl J Med; 2015 Nov; 373(21):2005-14. PubMed ID: 26412349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
    Cardoso F; Costa A; Norton L; Senkus E; Aapro M; André F; Barrios CH; Bergh J; Biganzoli L; Blackwell KL; Cardoso MJ; Cufer T; El Saghir N; Fallowfield L; Fenech D; Francis P; Gelmon K; Giordano SH; Gligorov J; Goldhirsch A; Harbeck N; Houssami N; Hudis C; Kaufman B; Krop I; Kyriakides S; Lin UN; Mayer M; Merjaver SD; Nordström EB; Pagani O; Partridge A; Penault-Llorca F; Piccart MJ; Rugo H; Sledge G; Thomssen C; Van't Veer L; Vorobiof D; Vrieling C; West N; Xu B; Winer E; ;
    Breast; 2014 Oct; 23(5):489-502. PubMed ID: 25244983
    [No Abstract]   [Full Text] [Related]  

  • 5. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
    Cardoso F; Costa A; Norton L; Senkus E; Aapro M; André F; Barrios CH; Bergh J; Biganzoli L; Blackwell KL; Cardoso MJ; Cufer T; El Saghir N; Fallowfield L; Fenech D; Francis P; Gelmon K; Giordano SH; Gligorov J; Goldhirsch A; Harbeck N; Houssami N; Hudis C; Kaufman B; Krop I; Kyriakides S; Lin UN; Mayer M; Merjaver SD; Nordström EB; Pagani O; Partridge A; Penault-Llorca F; Piccart MJ; Rugo H; Sledge G; Thomssen C; Van't Veer L; Vorobiof D; Vrieling C; West N; Xu B; Winer E
    Ann Oncol; 2014 Oct; 25(10):1871-1888. PubMed ID: 25234545
    [No Abstract]   [Full Text] [Related]  

  • 6. 1st International consensus guidelines for advanced breast cancer (ABC 1).
    Cardoso F; Costa A; Norton L; Cameron D; Cufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N; Pagani O; Senkus E; Thomssen C; Aapro M; Bergh J; Di Leo A; El Saghir N; Ganz PA; Gelmon K; Goldhirsch A; Harbeck N; Houssami N; Hudis C; Kaufman B; Leadbeater M; Mayer M; Rodger A; Rugo H; Sacchini V; Sledge G; van't Veer L; Viale G; Krop I; Winer E
    Breast; 2012 Jun; 21(3):242-52. PubMed ID: 22425534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.
    Baselga J; Bradbury I; Eidtmann H; Di Cosimo S; de Azambuja E; Aura C; Gómez H; Dinh P; Fauria K; Van Dooren V; Aktan G; Goldhirsch A; Chang TW; Horváth Z; Coccia-Portugal M; Domont J; Tseng LM; Kunz G; Sohn JH; Semiglazov V; Lerzo G; Palacova M; Probachai V; Pusztai L; Untch M; Gelber RD; Piccart-Gebhart M;
    Lancet; 2012 Feb; 379(9816):633-40. PubMed ID: 22257673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).
    Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; Tagliabue E; de Azambuja E; Makris A; Tampellini M; Dontu G; Van't Veer L; Harris AL; Fox SB; Dogliotti L; Bottini A
    J Natl Cancer Inst Monogr; 2011; 2011(43):147-51. PubMed ID: 22043063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer.
    Domchek SM; Mitchell G; Lindeman GJ; Tung NM; Balmaña J; Isakoff SJ; Schmutzler R; Audeh MW; Loman N; Scott C; Friedlander M; Kaufman B; Garber JE; Tutt A; Robson ME
    J Clin Oncol; 2011 Nov; 29(32):4224-6. PubMed ID: 21931031
    [No Abstract]   [Full Text] [Related]  

  • 10. Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.
    Mook S; Bonnefoi H; Pruneri G; Larsimont D; Jaskiewicz J; Sabadell MD; MacGrogan G; Van't Veer LJ; Cardoso F; Rutgers EJ
    Eur J Cancer; 2009 May; 45(7):1201-1208. PubMed ID: 19232484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
    Gebbia V; Gridelli C; Verusio C; Frontini L; Aitini E; Daniele B; Gamucci T; Mancuso G; Di Maio M; Gallo C; Perrone F; Morabito A
    Lung Cancer; 2009 Feb; 63(2):251-8. PubMed ID: 18632181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
    Smith I; Procter M; Gelber RD; Guillaume S; Feyereislova A; Dowsett M; Goldhirsch A; Untch M; Mariani G; Baselga J; Kaufmann M; Cameron D; Bell R; Bergh J; Coleman R; Wardley A; Harbeck N; Lopez RI; Mallmann P; Gelmon K; Wilcken N; Wist E; Sánchez Rovira P; Piccart-Gebhart MJ;
    Lancet; 2007 Jan; 369(9555):29-36. PubMed ID: 17208639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
    Maione P; Perrone F; Gallo C; Manzione L; Piantedosi F; Barbera S; Cigolari S; Rosetti F; Piazza E; Robbiati SF; Bertetto O; Novello S; Migliorino MR; Favaretto A; Spatafora M; Ferraù F; Frontini L; Bearz A; Repetto L; Gridelli C; Barletta E; Barzelloni ML; Iaffaioli RV; De Maio E; Di Maio M; De Feo G; Sigoriello G; Chiodini P; Cioffi A; Guardasole V; Angelini V; Rossi A; Bilancia D; Germano D; Lamberti A; Pontillo V; Brancaccio L; Renda F; Romano F; Esani G; Gambaro A; Vinante O; Azzarello G; Clerici M; Bollina R; Belloni P; Sannicolò M; Ciuffreda L; Parello G; Cabiddu M; Sacco C; Sibau A; Porcile G; Castiglione F; Ostellino O; Monfardini S; Stefani M; Scagliotti G; Selvaggi G; De Marinis F; Martelli O; Gasparini G; Morabito A; Gattuso D; Colucci G; Galetta D; Giotta F; Gebbia V; Borsellino N; Testa A; Malaponte E; Capuano MA; Angiolillo M; Sollitto F; Tirelli U; Spazzapan S; Adamo V; Altavilla G; Scimone A; Hopps MR; Tartamella F; Ianniello GP; Tinessa V; Failla G; Bordonaro R; Gebbia N; Valerio MR; D'Aprile M; Veltri E; Tonato M; Darwish S; Romito S; Carrozza F; Barni S; Ardizzoia A; Corradini GM; Pavia G; Belli M; Colantuoni G; Galligioni E; Caffo O; Labianca R; Quadri A; Cortesi E; D'Auria G; Fava S; Calcagno A; Luporini G; Locatelli MC; Di Costanzo F; Gasperoni S; Isa L; Candido P; Gaion F; Palazzolo G; Nettis G; Annamaria A; Rinaldi M; Lopez M; Felletti R; Di Negro GB; Rossi N; Calandriello A; Maiorino L; Mattioli R; Celano A; Schiavon S; Illiano A; Raucci CA; Caruso M; Foa P; Tonini G; Curcio C; Cazzaniga M
    J Clin Oncol; 2005 Oct; 23(28):6865-72. PubMed ID: 16192578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurance for independent cancer trials.
    Perrone F; Marangolo M; Di Costanzo F; Colucci G; Repetto L; Merlano M; De Placido S; Torri V; Comella G; Labianca R; Parisi V; Gallo C
    Ann Oncol; 2004 Nov; 15(11):1722-3. PubMed ID: 15520080
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.
    Di Maio M; Gridelli C; Gallo C; Manzione L; Brancaccio L; Barbera S; Robbiati SF; Ianniello GP; Ferraù F; Piazza E; Frontini L; Rosetti F; Carrozza F; Bearz A; Spatafora M; Adamo V; Isa L; Iaffaioli RV; Di Salvo E; Perrone F
    Br J Cancer; 2004 Jun; 90(12):2288-96. PubMed ID: 15162156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supportive care in patients with advanced non-small-cell lung cancer.
    Di Maio M; Perrone F; Gallo C; Iaffaioli RV; Manzione L; Piantedosi FV; Cigolari S; Illiano A; Barbera S; Robbiati SF; Piazza E; Ianniello GP; Frontini L; Veltri E; Castiglione F; Rosetti F; De Maio E; Maione P; Gridelli C; Rossi A; Barletta E; Barzelloni ML; Signoriello G; Bilancia D; Dinota A; Rosati G; Germano D; Lamberti A; Pontillo V; Brancacio L; Crispino C; Esposito M; Battiloro C; Tufano G; Cioffi A; Guardasole V; Angelini V; Guidetti G; Barbera S; Renda F; Romano F; Volpintesta A; Robbiati SF; Sannicolò M; Filipazzi V; Esani G; Gambaro A; Ferrario S; Tinessa V; Caprio MG; Zonato S; Cabiddu M; Raina A; Veltri E; D'Aprile M; Pistillucci G; Porcile G; Ostellino O; Vinante O; Azzarello G; Gebbia V; Borsellino N; Testa A; Gasparini G; Morabito A; Gattuso D; Romito S; Carrozza F; Fava S; Calcagno A; Grimi E; Bertetto O; Ciuffreda L; Parello G; Maiorino L; Santoro A; Santoro M; Failla G; Aiello RA; Bearz A; Sorio R; Scalone S; Clerici M; Bollina R; Belloni P; Sacco C; Sibau A; Adamo V; Altavilla G; Scimone A; Spatafora M; Bellia V; Hopps MR; Monfardini S; Favaretto A; Stefani M; Corradini GM; Pavia G; Scagliotti G; Novello S; Selvaggi G; Tonato M; Darwish S; Michetti G; Belometti MO; Labianca R; Quadri A; De Marinis F; Migliorino MR; Martelli O; Colucci G; Galetta D; Giotta F; Isa L; Candido P; Rossi N; Calandriello A; Ferraù F; Malaponte E; Barni S; Cazzaniga M; Gebbia N; Valerio MR; Belli M; Colantuoni G; Capuano MA; Angiolillo M; Sollitto F; Ardizzoia A; Luporini G; Locatelli MC; Pari F; Aitini E; Pedicini T; Febbraro A; Zollo C; Di Costanzo F; Bartolucci R; Gasperoni S; Gaion F; Palazzolo G; Galligioni E; Caffo O; Cortesi E; D'Auria G; Curcio C; Vasta M; Bumma C; Celano A; Bretti S; Nettis G; Anselmo A; Mattioli R; Nisticò C; Aschelter A; Foa P
    Br J Cancer; 2003 Sep; 89(6):1013-21. PubMed ID: 12966418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel.
    Crivellari D; Pagani O; Veronesi A; Lombardi D; Nolè F; Thürlimann B; Hess D; Borner M; Bauer J; Martinelli G; Graffeo R; Sessa C; Goldhirsch A;
    Ann Oncol; 2001 Mar; 12(3):353-6. PubMed ID: 11332148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
    Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Thürlimann B; Price KN; Coates AS; Hürny C; Bernhard J; Lindtner J; Collins J; Senn HJ; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
    J Clin Oncol; 2000 Apr; 18(7):1412-22. PubMed ID: 10735888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
    Pinder SE; Murray S; Ellis IO; Trihia H; Elston CW; Gelber RD; Goldhirsch A; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Gusterson BA
    Cancer; 1998 Oct; 83(8):1529-39. PubMed ID: 9781946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of thymidylate synthase expression in early breast cancer.
    Pestalozzi BC; Peterson HF; Gelber RD; Goldhirsch A; Gusterson BA; Trihia H; Lindtner J; Cortés-Funes H; Simmoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Allegra CJ; Johnston PG
    J Clin Oncol; 1997 May; 15(5):1923-31. PubMed ID: 9164203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.